Document Detail


N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.
MedLine Citation:
PMID:  19730428     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To evaluate resistance index (RI) changes in renal artery after N-acetylcysteine infusion in patients with systemic sclerosis. METHODS: In an open-label study 40 patients with systemic sclerosis (SSc) were treated with N-acetylcysteine (NAC) iv infusion over 5 consecutive hours, at a dose of 0.015 g x kg(-1) x h(-1). Renal haemodynamic effects were evaluated by color Doppler examination before and after NAC infusion. RESULTS: NAC infusion significantly reduced RI in a group of sclerodermic patients with early/active capillaroscopic pattern, modified Rodnan Total Skin Score (mRTSS) <14 and mild-moderate score to the vascular domain of Medsger Scleroderma Disease Severity Scale (DSS). RI increased after NAC infusion in patients with late capillaroscopic pattern, mTRSS>14 and severe-end stage score to the vascular domain of DSS. In patients with reduction of RI after NAC infusion, diffusion capacity for carbon monoxide mean value was significantly higher than in those patients with an increase of RI. No significant differences in renal blood flow were found between patients with different subsets of SSc. CONCLUSION: In patients with low disease severity NAC ameliorates vascular renal function.
Authors:
Edoardo Rosato; Rosario Cianci; Biagio Barbano; Ginevra Menghi; Antonietta Gigante; Carmelina Rossi; Enrico M Zardi; Antonio Amoroso; Simonetta Pisarri; Felice Salsano
Related Documents :
7332008 - Glomerular disease in two patients with urticaria-cutaneous vasculitis and hypocompleme...
11423578 - Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children.
17664788 - Evaluation and therapeutic outcome of palpable purpura.
6120348 - Basophil sensitisation in idiopathic nephrotic syndrome.
2111088 - A descriptive study of 42 cases of branhamella catarrhalis pneumonia.
21501268 - Validation of the chinese version of the functional performance inventory short form in...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Acta pharmacologica Sinica     Volume:  30     ISSN:  1745-7254     ISO Abbreviation:  Acta Pharmacol. Sin.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-04     Completed Date:  2009-11-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100956087     Medline TA:  Acta Pharmacol Sin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1283-8     Citation Subset:  IM    
Affiliation:
Sapienza University of Rome Department of Clinical Medicine, Clinical Immunology Unit-Scleroderma Center, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcysteine / therapeutic use*
Female
Free Radical Scavengers / therapeutic use*
Humans
Male
Microscopic Angioscopy
Middle Aged
Renal Artery / drug effects,  physiology
Renal Artery Obstruction / drug therapy*,  physiopathology
Scleroderma, Systemic / complications*,  physiopathology
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Free Radical Scavengers; 616-91-1/Acetylcysteine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epinephrine, phenylephrine, and methoxamine induce infiltrative anesthesia via alpha1-adrenoceptors ...
Next Document:  Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cel...